University of Bristol1y
Immortalised B-thalassemia and CDA IV erythroid lines
By reducing variability in place of ad-hoc patient samples it enables increased reliability and faster development of new therapeutics. Congenital dyserthropoietic anaemia IV (CDA IV) is a rare red ...